1. Home
  2. PAVS vs VIGL Comparison

PAVS vs VIGL Comparison

Compare PAVS & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVS
  • VIGL
  • Stock Information
  • Founded
  • PAVS 2004
  • VIGL 2020
  • Country
  • PAVS United States
  • VIGL United States
  • Employees
  • PAVS N/A
  • VIGL N/A
  • Industry
  • PAVS Medicinal Chemicals and Botanical Products
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAVS Health Care
  • VIGL Health Care
  • Exchange
  • PAVS Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • PAVS 90.2M
  • VIGL 89.3M
  • IPO Year
  • PAVS 2019
  • VIGL 2022
  • Fundamental
  • Price
  • PAVS $1.38
  • VIGL $2.76
  • Analyst Decision
  • PAVS
  • VIGL Strong Buy
  • Analyst Count
  • PAVS 0
  • VIGL 5
  • Target Price
  • PAVS N/A
  • VIGL $21.00
  • AVG Volume (30 Days)
  • PAVS 9.8K
  • VIGL 2.7M
  • Earning Date
  • PAVS 01-01-0001
  • VIGL 03-25-2025
  • Dividend Yield
  • PAVS N/A
  • VIGL N/A
  • EPS Growth
  • PAVS N/A
  • VIGL N/A
  • EPS
  • PAVS N/A
  • VIGL N/A
  • Revenue
  • PAVS $6,544,819.00
  • VIGL N/A
  • Revenue This Year
  • PAVS N/A
  • VIGL N/A
  • Revenue Next Year
  • PAVS N/A
  • VIGL N/A
  • P/E Ratio
  • PAVS N/A
  • VIGL N/A
  • Revenue Growth
  • PAVS N/A
  • VIGL N/A
  • 52 Week Low
  • PAVS $0.32
  • VIGL $1.49
  • 52 Week High
  • PAVS $2.48
  • VIGL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • PAVS 59.12
  • VIGL 70.15
  • Support Level
  • PAVS $1.32
  • VIGL $2.54
  • Resistance Level
  • PAVS $1.45
  • VIGL $2.88
  • Average True Range (ATR)
  • PAVS 0.06
  • VIGL 0.22
  • MACD
  • PAVS -0.01
  • VIGL 0.03
  • Stochastic Oscillator
  • PAVS 53.33
  • VIGL 85.19

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

Share on Social Networks: